ACBP/DBI neutralization for the experimental treatment of fatty liver disease.
Motiño O, Lambertucci F, Joseph A, Durand S, Anagnostopoulos G, Li S, Carbonnier V, Nogueira-Recalde U, Montégut L, Chen H, Aprahamian F, Nirmalathasan N, Maiuri MC, Pietrocola F, Valla D, Laouénan C, Gautier JF, Castera L; QUID NASH Investigators; Martins I, Kroemer G.
Motiño O, et al. Among authors: kroemer g.
Cell Death Differ. 2024 Nov 16. doi: 10.1038/s41418-024-01410-6. Online ahead of print.
Cell Death Differ. 2024.
PMID: 39550516